PerkinElmer, Inc. (PKI) Declares $0.07 Quarterly Dividend

PerkinElmer, Inc. (NYSE:PKI) declared a quarterly dividend on Monday, July 24th, RTT News reports. Shareholders of record on Friday, October 20th will be given a dividend of 0.07 per share by the medical research company on Friday, November 10th. This represents a $0.28 annualized dividend and a yield of 0.44%. The ex-dividend date is Thursday, October 19th.

PerkinElmer has a dividend payout ratio of 9.7% meaning its dividend is sufficiently covered by earnings. Analysts expect PerkinElmer to earn $3.24 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 8.6%.

PerkinElmer (NYSE:PKI) traded down 0.30% on Friday, reaching $63.47. The company’s stock had a trading volume of 403,207 shares. The stock has a market cap of $7.00 billion, a PE ratio of 19.14 and a beta of 0.75. PerkinElmer has a 12-month low of $45.35 and a 12-month high of $70.16. The company’s 50 day moving average price is $66.79 and its 200-day moving average price is $61.18.

PerkinElmer (NYSE:PKI) last posted its earnings results on Thursday, August 3rd. The medical research company reported $0.67 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.67. The business had revenue of $547 million during the quarter, compared to analyst estimates of $554.14 million. PerkinElmer had a return on equity of 13.44% and a net margin of 16.80%. The company’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.67 EPS. On average, equities analysts expect that PerkinElmer will post $2.89 EPS for the current year.

In related news, Director Peter Barrett sold 10,000 shares of PerkinElmer stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $63.22, for a total transaction of $632,200.00. Following the transaction, the director now directly owns 29,200 shares in the company, valued at $1,846,024. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Andrew Okun sold 4,358 shares of PerkinElmer stock in a transaction on Monday, June 19th. The shares were sold at an average price of $65.00, for a total value of $283,270.00. Following the transaction, the insider now owns 16,799 shares in the company, valued at $1,091,935. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by BNB Daily and is owned by of BNB Daily. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/20/perkinelmer-inc-declares-quarterly-dividend-of-0-07-pki-updated-updated-updated.html.

PKI has been the subject of a number of research analyst reports. Piper Jaffray Companies lifted their target price on PerkinElmer to $80.00 and gave the stock an “overweight” rating in a report on Tuesday, July 25th. Morgan Stanley reissued an “overweight” rating and issued a $79.00 target price (up previously from $73.00) on shares of PerkinElmer in a report on Monday, July 10th. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research note on Tuesday, August 1st. Evercore ISI restated an “in-line” rating and issued a $68.00 price target (up from $62.50) on shares of PerkinElmer in a research note on Thursday, June 22nd. Finally, Citigroup Inc. raised their price target on PerkinElmer from $67.00 to $74.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company. PerkinElmer has a consensus rating of “Hold” and a consensus price target of $67.00.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Dividend History for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply